Navigation Links
Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
Date:5/28/2008

ard of Directors of the American Society of

Clinical Oncology and the American Association of Cancer Institutes. He

is past chair of ASCO's Cancer Research Committee and of the Cancer

Communications Committee. He is the author of many scientific

publications and has served on the editorial boards of the

International Journal of Gynecologic Cancer, International Journal of

Oncology, Cancer Research, Cancer Investigation, Journal of

Experimental Therapeutics and Oncology and Clinical Cancer Research. He

earned his bachelor's degree in chemistry, Ph.D. and M.D. from the

University of Rochester. He completed his medical training at

Dartmouth-Hitchcock Medical Center and a medical oncology fellowship at

the National Cancer Institute.

-- Everett E. Vokes, M.D., is the John E. Ultmann Professor of Medicine

and Radiation and Cellular Oncology at the University of Chicago

Pritzker School of Medicine; director of the Section of

Hematology/Oncology; vice chairman for clinical research in the

Department of Medicine; director of the head and neck oncology program;

and deputy director of the University of Chicago Cancer Research

Center. He serves as chair of the Cancer and Leukemia Group B,

Respiratory Core Committee. He is the recipient of numerous research

grants and has authored more than 300 publications in peer-reviewed

journals. He received his medical degree from the University of Bonn

Medical School in West Germany and completed his residency at

Ravenswood Hospital in Chicago and at the University of Southern

California in Los Angeles. He completed a fellowship in

hematology/oncology at the University of Chicago.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and comme
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
2. Poniard Pharmaceuticals Announces Upcoming Conference Participation
3. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
4. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
5. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
6. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
7. XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
8. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
9. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
10. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
11. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014  Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
(Date:7/10/2014)... Cleveland, Ohio (PRWEB) July 10, 2014 ... in ion channel-expressing cell lines, and the gap that ... new cells that expand its industry-leading portfolio of validated ... focuses on ion channel-expressing cell lines, as ion channels ... able to control this activity creates the potential to ...
(Date:7/10/2014)... 10, 2014 EvoDerma ’s NOOME Anti-Aging ... rejuvenating device now comes with a second treatment cup to ... , The new cup is thinner on the edges for ... target rough, thin and uneven surfaces on the face, neck ... a stimulating treatment on areas such as the cheeks and ...
(Date:7/10/2014)... July 10, 2014 /PRNewswire-iReach/ -- Tute Genomics, ... today announced an agreement with Lineagen, Inc., ... Lineagen,s NextStep Dx PLUS.  Lineagen, focused ... neurological disorders, currently offers FirstStep Dx ... service used by healthcare providers as a ...
Breaking Biology Technology:Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4
... The Beaumont Technology,Usability Center (BTUC) will offer ... technology companies speed their product commercialization,process. ... BTUC product-usability and,human-factors experts to conduct a ... risk assessment requirements. In early 2008, the,organizations ...
... focus on Next Generation Sequence Analysis Problem -, ... Genomics Search Tool -, MISSION VIEJO, Calif., ... community for its innovative genomic search,technology, SLIM Search, ... Institute,s (CHI) Second International Next Generation,Sequencing Conference. The ...
... Calif., Sept. 26 Jazz,Pharmaceuticals, Inc. (Nasdaq: ... Executive Chairman, will provide a corporate presentation at ... NY on October 8,2007 at 8:00 a.m. Eastern ... may be accessed by visiting the,Investors section of ...
Cached Biology Technology:Beaumont Technology Usability Center To Offer Training For Medical Technology Companies 2SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market 2SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market 3SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market 4
(Date:7/11/2014)... German . ... the refraction of X-rays through a specimen instead of ... method are often of much higher quality than those ... Prof. Franz Pfeiffer are particularly interested in developing new ... X-ray phase-contrast imaging. One main goal is to make ...
(Date:7/11/2014)... Shenzhen, July 10, 2014---A team of researchers from The ... have identified a gene of wild soybean linked to ... to grow in saline soil. This study published online ... to unveil novel genomic information for crop improvement. , ... to domestication and human selection, cultivated soybeans have less ...
(Date:7/11/2014)... An international team of researchers, including scientists from the ... just a reported a major step in understanding photosynthesis, ... now maintains the oxygen in its atmosphere and which ... on earth. , The researchers report the first ... reaction, namely the step in which a specific protein ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2BGI reports a novel gene for salt tolerance found in wild soybean 2A first direct glimpse of photosynthesis in action 2
... environmental engineer has received a three-year, $561,730 grant to identify ... water providers can take action to contain and curb the ... Foundation have awarded Assistant Professor Hyeok Choi the grant to ... exist so that the harmful algae can be monitored. , ...
... mouth are telling Oak Ridge National Laboratory scientists something ... code of bacteria linked to the condition. The ... of Sciences , profiles the SR1 bacteria, a group ... mouth to deep within the Earth, that have never ...
... the most widely advocated strategies for dealing with HIV/AIDS could ... of men who have sex with men (MSM) in LA ... In the United States, LA County has the largest ... and treat" policy which calls for universal testing for ...
Cached Biology News:UT Arlington engineer to search for bad algal blooms 2Human microbe study provides insight into health, disease 2Study: Widespread 'test-and-treat' HIV policies could increase dangerous drug resistance 2
...
...
... System is an imaging based plate ... and high throughput screening which can ... The Hamamatsu light sources and cameras ... decades-long experience in photon detection technology. ...
... pCITE-2a-c(+) vectors are designed for enhanced translation of ... e.g. rabbit reticulocyte lysate. The maps for pCITE-2b(+) ... the following exceptions: pCITE-2b(+) is a 3793 bp ... I and Xcm I sites. Subtract 7 bp ...
Biology Products: